Gene · 5873
Papers3,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mammary Fibroblasts Secrete Damage Associated Molecular Patterns through Extracellular Vesicles in Response to Ionizing Radiation. | bioRxiv | 2025 | 41394744 | PubTator, text mining | PubMed |
| Oxidative Stress Influences Exosome Biogenesis by Inducing Cellular Senescence in Uterine Adenocarcinoma Ishikawa Cells. | Iran J Med Sci | 2025 | 41377903 | PubTator, text mining | PubMed |
| Unveiling Heterogeneity: Innovations and Challenges in Single-Vesicle Analysis for Clinical Translation. | J Extracell Vesicles | 2025 | 41316984 | PubTator, text mining | PubMed |
| A Nationwide Analysis of the Phenotype/Genotype Landscape of Hemophagocytic Lymphohistiocytosis: UNC13D Associates with Poor Prognosis. | Genes (Basel) | 2025 | 41300767 | PubTator, text mining | PubMed |
| The RAB27A effector SYTL5 regulates mitophagy and mitochondrial metabolism. | Elife | 2025 | 41294009 | PubTator, text mining | PubMed |
| Fluid shear stress-mediated upregulated exosomal-IGF2 promotes hepatocellular carcinoma cell migration and metastasis. | Am J Cancer Res | 2025 | 41244125 | PubTator, text mining | PubMed |
| Rab27a-mediated exosome secretion facilitates classical swine fever virus release and immune evasion. | J Virol | 2025 | 41217171 | PubTator, text mining | PubMed |
| Extracellular Vesicle-Mediated Regulation of H3C14 Contributes to Gemcitabine Resistance in Bladder Cancer. | J Extracell Vesicles | 2025 | 41159684 | PubTator, text mining | PubMed |
| Griscelli Syndrome Type 2 Revealed by Macrophage Activation Syndrome: Two Cases From the Same Family. | Cureus | 2025 | 41141165 | PubTator, text mining | PubMed |
| Exosome miRNA sorting controlled by RNA-binding protein-motif interactions. | Extracell Vesicles Circ Nucl Acids | 2025 | 41132505 | PubTator, text mining | PubMed |
| Extracellular vesicles: cargo loading, degradation and secretory pathways, and their intersection with autophagy. | Extracell Vesicles Circ Nucl Acids | 2025 | 41132500 | PubTator, text mining | PubMed |
Tubular-Cell-Derived Extracellular Vesicle miR-491-3p Aggravates Renal Ischemia-Reperfusion Injury by Inhibiting Macrophage SIRT1-Mediated Notch Intracellular Domain Deacetylation-Driven Ubiquitin-Proteasome Degradation. | Research (Wash D C) | 2025 | 41112091 | PubTator, text mining | PubMed |
| Vesicular transport in the autophagic route: RAB GTPases as pivotal regulators of autophagy. | Biochem J | 2025 | 41108106 | PubTator, text mining | PubMed |
| Germline determinants of toxicity and efficacy in patients with large B-cell lymphoma treated with CAR T-cell therapy. | J Immunother Cancer | 2025 | 41067879 | PubTator, text mining | PubMed |
| Bio fluid exosomes: promises, challenges, and future directions in translational medicine. | J Transl Med | 2025 | 40988065 | PubTator, text mining | PubMed |
| Molecular requirements for mammalian crinophagy highlight a key role for Ca2+-dependent Munc13-4. | Res Sq | 2025 | 40951263 | PubTator, text mining | PubMed |
| Stem Cell-Derived Exosomes: A Comprehensive Review of Biomedical Applications, Challenges, and Future Directions. | Int J Nanomedicine | 2025 | 40933023 | PubTator, text mining | PubMed |
| Targeted Blockage of Pathological Extracellular Vesicles and Particles From Fibroblast-Like Synoviocytes for Osteoarthritis Relief: Proteomic Analysis and Cellular Effect. | J Extracell Vesicles | 2025 | 40919882 | PubTator, text mining | PubMed |
| Advances in Neurodegenerative Disease Therapy: Stem Cell Clinical Trials and Promise of Engineered Exosomes. | CNS Neurosci Ther | 2025 | 40904199 | PubTator, text mining | PubMed |
| Cancer Cell-Secreted miR-33a Reduces Stress Granule Formation by Targeting Polyamine Metabolism in Stroma to Promote Tumourigenesis. | J Extracell Vesicles | 2025 | 40903826 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5873/papers?page=5